Vident Advisory’s Nu Skin NUS Stock Holding History

Vident Advisory’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-37,267	Closed	-$393K	–	1505
2024 Q2	$393K	Buy	37,267 +12,026	+48%	+$152K	0.01%	1018
2024 Q1	$349K	Buy	25,241 +11,876	+89%	+$185K	0.01%	960
2023 Q4	$260K	Buy	+13,365	New	+$247K	0.01%	1069

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vident Advisory's NUS Position: Q3 2024 in Review

Vident Advisory sold out of Nu Skin (NUS) in Q3 2024, closing a stake of 37,267 shares — an estimated $393K sold.

Vident Advisory first reported a position in NUS in Q4 2023 and held it in 3 quarters. The position peaked at $393K in Q2 2024. 203 funds tracked by Wall St. Rank hold NUS as of Q3 2024.

Vident Advisory reported no remaining Nu Skin position as of Q3 2024 after selling out during the quarter.
Vident Advisory sold 37,267 Nu Skin shares in Q3 2024, an estimated $393K.
Vident Advisory first reported a position in Nu Skin in Q4 2023 and held it in 3 quarters.
Vident Advisory's Nu Skin position peaked at $393K in Q2 2024.
203 funds tracked by Wall St. Rank held Nu Skin as of Q3 2024.

Based on Vident Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.